Stem cell therapy with overexpressed VEGF and PDGF genes improves cardiac function in a rat infarct model.
Therapeutic potential was evaluated in a rat model of myocardial infarction using nanofiber-expanded human cord blood derived hematopoietic stem cells (CD133+/CD34+) genetically modified with VEGF plus PDGF genes (VIP).Myocardial function was monitored every two weeks up to six weeks after therapy....
Main Authors: | Hiranmoy Das, Jon C George, Matthew Joseph, Manjusri Das, Nasreen Abdulhameed, Anna Blitz, Mahmood Khan, Ramasamy Sakthivel, Hai-Quan Mao, Brian D Hoit, Periannan Kuppusamy, Vincent J Pompili |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2009-10-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC2752797?pdf=render |
Similar Items
-
Ex Vivo Nanofiber Expansion and Genetic Modification of Human Cord Blood-Derived Progenitor/Stem Cells Enhances Vasculogenesis
by: Hiranmoy Das Ph.D., et al.
Published: (2009-03-01) -
Rat Hippocampal Neural Stem Cell Modulation Using PDGF, VEGF, PDGF/VEGF, and BDNF
by: Neus Gomila Pelegri, et al.
Published: (2019-01-01) -
Supplemental Oxygen Protects Heart Against Acute Myocardial Infarction
by: Anjali M. Prabhat, et al.
Published: (2018-08-01) -
Serial measurements of serum PDGF-AA, PDGF-BB, FGF2, and VEGF in multiresistant ovarian cancer patients treated with bevacizumab
by: Madsen Christine, et al.
Published: (2012-09-01) -
Human ovarian tumor cells escape γδ T cell recognition partly by down regulating surface expression of MICA and limiting cell cycle related molecules.
by: Jingwei Lu, et al.
Published: (2011-01-01)